ARCK’s science is centered on localized delivery and tissue-level biologic modulation—designed to address acute pain at its source while avoiding systemic exposure and dependency risk.
Our Scientific Approach
ARCK’s biologic platform is built on targeted delivery, tissue engagement, and biologic modulation—aimed at treating acute pain where it originates within injured, inflamed, and stressed tissues.
How the Therapy Works
1. Targeted Delivery
Biologic therapy is delivered directly to the injured tissue, reducing systemic exposure and improving precision.
2. Tissue-Level Engagement
The biologic interacts with local cellular signaling pathways linked to pain and tissue stress.
3. Modulation & Recovery
Engineered to modulate pain pathways, increase blood flow, and support natural, biologic recovery processes.
Why a Non-Opioid Biologic?
- One and done treatment resulting in no dependency or withdrawal risk
- No systemic analgesic side effects
- Designed for rapid onset and durable relief
- Ideal for safer, modern pain management protocols
Preclinical Foundation
Early-model observations demonstrate strong biological rationale, supporting Phase III clinical trials in 2026.
